https://orcid.org/0000-0002-9281-9202
Figures
Abstract
Prior studies have identified various determinants of differential immune responses to COVID-19. This study focused on the Ig-G anti-RBD marker, analyzing its potential correlations with sex, vaccine type, body fat percentage, metabolic risk, perceived stress, and previous COVID-19 exposure. In this study, data (available in S1 Data) were obtained from 108 participants from the ESFUERSO cohort, who completed questionnaires detailing their COVID-19 experiences and stress levels assessed through the SISCO scale. IgG anti-RBD concentrations were quantified using an ELISA assay developed by UNAM. Multiple regression analysis was employed to control for covariates, including sex, age, body fat percentage, body mass index (BMI), and perceived stress. This sample comprised young individuals (average age of 21.4 years), primarily consisting of females (70%), with a substantial proportion reporting a family history of diabetes, hypertension, or obesity. Most students had received the Moderna or Pfizer vaccines, and 91% displayed a positive anti-RBD response. A noteworthy finding was the interaction between body fat percentage and sex. In males, increased adiposity was associated with decreased Ig-G anti-RBD concentration; in females, the response increased. Importantly, this pattern remained consistent regardless of the vaccine received. No significant associations were observed for dietary habits or perceived stress variables. This research reports the impact of sex and body fat percentage on the immune response through Ig-G anti-RBD levels to COVID-19 vaccines. The implications of these findings offer a foundation for educational initiatives and the formulation of preventive policies aimed at mitigating health disparities.
Citation: Perales-Torres AL, Perez-Navarro LM, Garcia-Oropesa EM, Diaz-Badillo A, Martinez-Lopez YE, Rosas M, et al. (2024) Influence of adiposity and sex on SARS-CoV-2 antibody response in vaccinated university students: A cross-sectional ESFUERSO study. PLOS Glob Public Health 4(7): e0002686. https://doi.org/10.1371/journal.pgph.0002686
Editor: Abram L. Wagner, University of Michigan, UNITED STATES OF AMERICA
Received: November 12, 2023; Accepted: July 1, 2024; Published: July 26, 2024
Copyright: © 2024 Perales-Torres et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The dataset is available at https://scholarworks.utrgv.edu/cgi/ir_submit.cgi?context=som_pub.
Funding: This study was supported by a grant for ALPT from COTACYT-2021-01-23, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparationof the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Sex differences in metabolism and insulin resistance have been demonstrated in our previous studies with children [1–3]. Similar findings from various cultural and social contexts support differences in insulin resistance and metabolic-associated liver disease in adults [4]. These differences are partly due to the protective effect of endogenous estrogens on various tissues, including brain, liver, skeletal muscle, adipose tissue, and pancreatic beta cells [5], and other underlying mechanism such as AMPdependent protein kinase (AMPK) activation [6].
Immune responses influenced by sex differences, particularly in LTR8, were reported during the COVID-19 pandemic [7]. Other studies have investigated factors that impact the serum levels of antibodies produced by the COVID-19 vaccine [8–10]. Age is a critical factor that plays a significant role in determining the immune response. Elderly individuals with obesity and non-prior infection had reduced antibody titers against SARS-CoV-2 spike antigen after CoronaVac vaccine (manufactured in China) compared to non-obese people [11]. Lower antibody response after receiving two doses of the Pfizer vaccine has also been linked to central obesity (correlation of r = -0.3), the presence of hypertension, and smoking habits, with no notable differences by gender [12].
During the pandemic, it became evident that metabolic imbalances associated with obesity could increase the severity of COVID-19 and the risk of mortality [13, 14]. Diet can induce metabolic and immune impairments, which may vary based on sex, as shown in animal studies [15, 16]. Interestingly, losing weight has been shown to improve the adaptive immune response, particularly an increase in INF-g2 levels following the administration of two doses of mRNA vaccine [17].
Sex and body weight interaction can also result in varying immune responses. For individuals with a BMI >40 kg/m2, there were no discernible differences in IgG antibody levels between the sexes [18]. In contrast, those with normal weight showed higher levels among males [19]. Physical activity and migration have influenced immunological markers and health outcomes [20, 21]. Psychological stress is another recognized variable affecting the immune response [22, 23] Early-life adversity, affecting 39% of the world’s population, has been associated with neuroinflammation and increased levels of soluble tumor necrosis factor in animal studies [24]. Diet and stress can serve as effect modifiers of biological variables like sex and adiposity.
The present study focused on a nested sample of students from the ESFUERSO (EStudio de la Frontera Urbana para las EnfeRmedades y factores aSociados a la Obesidad) program. These students experienced the impact of the COVID-19 pandemic, which forced them into home confinement and led to changes in their habits.
The development of mRNA vaccines has been a long journey, beginning with cell cultures and laboratory animal testing, followed by industry investment and veterinary applications, ultimately leading to human vaccination in 2020. These efforts have been ongoing for three decades [25].
This study aimed to analyze the mathematical function of the immune response to the receptor-binding domain (RBD), a protective epitope found in the S protein [26], by examining the Ig-G response among young students from Mexico living near the US-Mexico border. The analyzed factors included sex, body fat, psychological stress, and food consumption (Fig 1A).
The top panel (A) presents the initial hypothesis, in which we expected sex and body fat to affect the immune response to COVID-19 vaccination, with psychological factors and food ingestion acting as effect modifiers. The bottom panel (B) concludes that the immune response differed between males (trend to negative association) and females (trend to positive association), and the effect modifiers did not play a role in this study.
Methods
Study sample
In 2018, the ESFUERSO cohort study was initiated, focusing on 500 first-year students from two universities in Reynosa, Tamaulipas. Characteristics of this sample were described elsewhere [27]. In summary, 70% of the participants were considered to have metabolic risk if they had a BMI > 30 or a family history of obesity, diabetes, or hypertension.
For the current study, we intended a proportional sample with 70% of students with metabolic risk who accepted to participate and could attend near the university facilities. Due to the pandemic, not all students could attend, and only a subset of 116 students were contacted between September 1st and October 31st, 2021. During this period, we obtained signed informed consent (see Ethics Statement below for details), conducted questionnaire surveys, collected anthropometric measurements, and collected blood samples from 108 students in compliance with the COVID-19 protocol managed by the universities. Eight students initially agreed to participate but did not complete the surveys or clinical measurements.
Measures
The questionnaires and methods used in the ESFUERSO study have been described elsewhere [27]. Briefly, the questionnaires collected information on family metabolic risk, anxiety, depression, and uncertainty. The Cronbach α coefficient from each question ranged from 0.72–0.96. The test-retest for agreement in categorical variables was a kappa coefficient between 0.5–0.91 and an intraclass correlation coefficient between 0.73–0.96 in continuous variables. The stress during the pandemic was evaluated with SISCO (Modelo SIStémico COgnoscitivista para el estudio del estrés académico), to assess distress, uncertainty, lack of sleep, sadness, and anxiety. The SISCO was validated in Mexico and other Latin American countries with a Cronbach α coefficient of 0.9 with high homogeneity [28]. The food ingestion scores were calculated using a semi-quantitative questionnaire about 42 selected regional foods. The weighted kappa was greater than 0.6 for all items in a reliability study [29]. All the questionnaires were administered electronically, with students completing them on their cell phones. This approach ensured efficient data collection and minimized the need for physical paperwork or in-person administration.
Weight, height, and acanthosis nigricans grade [30] were assessed and registered at the universities by a standardized nutritionist [27]. The body fat percentage was measured by bioelectrical impedance using a body composition analyzer (Tanita TBF-300A). Blood samples were obtained between 7 to 9 am (after an overnight fasting period) for the measurement of serum concentration of Ig-G anti-RBD by indirect ELISA [26]. The samples underwent centrifugation following collection, and four aliquots were stored at -20 C. These aliquots were transported to Mexico City in cold conditions in November 2021 for antibody analysis. The effective neutralizing concentration of anti-RBD IgG was assessed, and this variable was analyzed in both continuous and dichotomous dimensions. A threshold of 1.0 for the anti-RBD IgG ratio was established to differentiate between effective and non-effective neutralization.
Statistical analysis
Descriptive statistics included percentages for categorical variables and means with standard deviations or medians and interquartile range (Q1, Q3) for continuous variables. Inferential statistics utilized regression analysis to evaluate the relation in the SISCO questionnaire scores; the food ingestion scores with 42 selected regional foods were reduced to 12 factors (KMO = 0.64 supporting suitability analysis for principal components and varimax rotation) [29]. Locally weighted regression (lowess) was performed to assess nonlinear relationships. The analysis used antibody concentration as the dependent variable, adjusting for sex, age, metabolic risk, body fat percentage, and BMI. Multiplicative interactions for covariates were analyzed. The variance inflation factor (VIF) was calculated to evaluate multicollinearity in variables used in linear models without interactions [31]. Multicollinearity occurs when two or more independent variables in a regression model are highly correlated, making accurately estimating each variable’s effect on the dependent variable difficult. The VIF quantifies the extent to which multicollinearity increases an estimated regression coefficient’s variance (i.e., the uncertainty or variability) [32, 33].
We evaluated three models (presented in Table 2) covering sex, body fat, psychological variables, and food ingestion; some included an interaction term for body fat percentage and sex. The models included first—to third-grade polynomial multiple regression, and the goodness of fit was assessed using a squared error calculation. The best goodness of fit for data was achieved with polynomial multiple regression using a sample of 108 students with complete data. All analyses were performed with Stata V18.0 (StataCorp, College Station, TX).
Ethics statement
The protocol and informed consent were approved by the Comite de Etica Institucional de la Unidad Academica Multidisciplinaria Reynosa-Aztlan (CEI-UAMRA) number registration CEI-UAMRA 005/2019/CEI under Health normativity (NOM-012-SSA-3-212). The informed consent detailed the risks and benefits and ensured no cost to the participants, who had the right to withdraw from the project without any questions. All participants signed the approved informed consent. The present report followed the STROBE recommendations for cross-sectional studies [34].
Results
A total of 108 students in the ESFUERSO cohort were enrolled during the 3rd year of the cohort follow-up in Reynosa. The participants had a mean age of 21.4 (SD 1.0) years, an average BMI of 27.9 (SD 6.2), and gender distribution of 69% (75 out of 108) female students. The presence of T2D, hypertension, obesity, or a combination of the conditions was identified in 70% of the students. Notably, there were no discernible differences between universities on metabolic risk, anthropometry, sex, and commercial brand of vaccine or the presence of adequate antibody levels (Table 1). Only 3 (3%) of the students from the private university had no COVID-19 vaccination at the time of the study, and they also belonged to the metabolic risk group (Pearson standardized distance >3.0). From vaccinated students, 97 (90%) were immunized with Moderna or Pfizer, and only 8 (7%) with other vaccines (Johnson & Johnson n = 1, Cansino n = 6, Sinovac n = 1). The prevalence of positive anti-RBD was 91%, with similar values by sex (Table 1).
The multicollinearity analysis showed BMI and fat percentage had VIF = 4.8 and 1/VIF = 0.02. This suggested a moderate level of collinearity, so we analyzed separating both variables to maintain a clear interpretation of the regression coefficients. The anthropometric analysis showed the body fat percentage had the lowest BIC (BIC = 259.9) compared with BMI (BIC = 261.2) and waist circumference (BIC = 264.4). Table 2 shows the results of body fat percentage with sex interaction. The body fat percentage interaction with sex was statistically significant, supporting the serum concentration of anti-RBD decreased as adiposity increased in men (p = 0.034 for a second-grade term). Still, anti-RBD increased with adiposity in women (p = 0.01, p = 0.015 for second and third-grade terms) (Fig 2). The interaction remained despite the vaccine types. The adjusted model minimized the mean squared error (Root MSE = 0.74) and adjusted coefficient of determination (R^2 = 0.08), compared with other models (Fig 3 and Table 2). The residuals adjusted to a normal distribution (Shapiro-Wilkins p = 0.136).
This figure illustrates the relationship between neutralizing anti-RBD (Receptor Binding Domain) IgG ratios and body fat percentage among university students, using the Lowess (Locally Weighted Regression) smoothing technique to highlight trends. Females and males are distinguished by diamonds and crosses, respectively, with the Lowess curve for females presented as a continuous line and for males as a dashed line.
This figure shows the relationship between anti-RBD IgG ratios and body fat percentage for university students, modeled with a polynomial regression to capture the nuances of this relationship. A 3rd-degree polynomial regression is applied for females and a 2nd-degree polynomial for males, reflecting the differential complexity of their responses. Females are depicted with white circles, and males with black circles.
No differences due to metabolic risk factors or effective antibody concentration were found for food consumption and psychological variables (distress, uncertainty, lack of sleep, sadness, and anxiety) presented in Table 2.
Discussion
Based on the results of our study, it appears that the neutralizing anti-RBD response to the COVID-19 vaccine is influenced by a multiplicative interaction of sex and body fat percentage. Specifically, females tend to have increased responses, while males tend to have decreased responses (Fig 3). Stress scores do not appear to have significant effects (Fig 1B).
This observation aligns with existing research on sex-based differences in immune responses. For instance, a study involving the Cameron County Hispanic Cohort, which included 624 participants with a mean age of 50 (SD 14) years, has previously reported sex-specific variations in adipokines and carotid intima-media thickness [35]. The present study extends these findings to a younger cohort, specifically individuals in the final stages of adolescence residing near the U.S.-Mexico border. This highlights the relevance of considering age and geographic location when examining immune response differences between sexes.
Another study conducted in Mexico on 980 adult participants with a median age of 50 (Q1: 36, Q3: 54) who had obesity before mass vaccination sheds light on this [36]. The authors identified independent factors associated with SARS-Cov-2 infection in a symptomatic group. Their findings revealed higher levels of anti-S1/2 antibodies in individuals with advanced age, type 2 diabetes, hypertension, and a positive correlation with BMI [36]. Furthermore, women exhibited higher levels of anti-RBD IgG antibodies compared to men. The authors emphasized the vulnerability of individuals with underlying health conditions, including obesity, to SARS-CoV-2 infection, a concern that is particularly pronounced in older populations. While our study focuses on a younger cohort, providing valuable insights into this demographic group.
Other populations have reported similar findings. Yamamoto et al. [37], reported sex–associated differences in the relationship between body mass index and SARS-CoV-2 antibody titers following the BNT162b2 vaccine in a study of 2,435 healthcare workers in Japan. A meta-analysis examining antibody responses to COVID-19 vaccinations also indicated a significant association between obesity and reduced antibody response [38]. Nevertheless, the considerable heterogeneity (88%) observed across studies suggests that biological factors, including sex, age, and body fat, play a pivotal role in these outcomes.
Tailoring vaccination plans based on an individual’s characteristics may enhance vaccine effectiveness. Addressing sex-specific and body fat-related factors in public health interventions can reduce infection rates. Considering the social determinants in the U.S.-Mexico border region, the information provided in this study can help in programs to educate individuals about their susceptibility to infections.
One strength of the study was that the interaction terms captured the combined effect of how body fat percentage and sex jointly influence the antibody response to a vaccine. Another was evaluating multiple models, including first—to third-degree polynomial regressions (non-linear models), which allowed for a comprehensive data analysis. This approach helped determine the best model that fits the data, ensuring robust and reliable results.
While the present study yields valuable insights, it is important to acknowledge several potential limitations. Variations in immune responses across different age groups, the influence of genetic factors, and the impact of social determinants can introduce complexities that our study may not fully capture. Moreover, it’s essential to recognize that the study’s cross-sectional design allows for identifying associations but does not establish causality. These considerations emphasize the need for caution in generalizing the findings and highlight avenues for further research.
Conclusion
This study provides novel insights into the response of anti-RBD IgG antibodies to vaccination in a young cohort. The findings reveal a complex relationship between sex and body fat percentage, depicted by a third-degree polynomial curve (Fig 3). This emphasizes the intricate interplay between body fat and the immune response to vaccines and accentuates the importance of considering sex-specific factors, especially among younger individuals. The complexity of these interactions supports the need for further studies that explicitly include the analysis of sex and fat percentage. Comprehensive knowledge of distinct characteristics and immunological responses helps to understand social and biological dynamics for tailoring vaccination strategies, optimizing public health interventions, and reducing health disparities.
Supporting information
S1 Checklist. Inclusivity in global research.
https://doi.org/10.1371/journal.pgph.0002686.s001
(DOCX)
Acknowledgments
Preliminary results of this study were presented and recognized as the best oral clinical presentation at the UTRGV School of Medicine’s 5 th Annual Research Symposium, 2021, Mission, TX. The study was supported by a grant to ALPT from the Convocatoria 2021–01: Impulso a la Investigación Científica y de Tecnología Aplicada, COTACyT grant number: COTACYT-2021-01-23. The authors acknowledge the generous support the Universidad Mexico Americana del Norte, the Universidad Autónoma de Tamaulipas for supporting ESFUERSO sharing spaces, personnel, laboratory facilities, and the enthusiastic participation of alumni, staff, and faculty. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
References
- 1. Garibay-Nieto N, Hernandez-Moran BA, Villanueva-Ortega E, Garces-Hernandez MJ, Pedraza-Escudero K, Arroyo-Valerio A, et al. Comparison of Carotid Intima-Media Thickness in Children and Adults With and Without Obesity: A Hysteresis Model. Endocr Pract. 2022;28(3):315–20. Epub 20211208. pmid:34890785.
- 2. Garces-Hernandez MJ, Pedraza-Escudero K, Garibay-Nieto N, Hernandez-Ruiz J, Prieto-Chavez JL, Arriaga-Pizano LA, et al. The CCR2(+) Monocyte Subsets Increase in Obese Boys but Not Girls with Abnormally High Carotid Intima-Media Thickness: A Pilot Study. J Cardiovasc Dev Dis. 2022;9(10). Epub 20220929. pmid:36286282; PubMed Central PMCID: PMC9604509.
- 3. Villanueva-Ortega E, Garces-Hernandez MJ, Herrera-Rosas A, Lopez-Alvarenga JC, Laresgoiti-Servitje E, Escobedo G, et al. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. Ann Hepatol. 2019;18(5):693–700. Epub 20190522. pmid:31151875.
- 4. Wei Y, Liu J, Wang G, Wang Y. Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults. Biol Sex Differ. 2023;14(1):69. Epub 20231009. pmid:37814297; PubMed Central PMCID: PMC10561490.
- 5. Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453–61. Epub 20191121. pmid:31754750; PubMed Central PMCID: PMC6997275.
- 6. Kvandova M, Puzserova A, Balis P. Sexual Dimorphism in Cardiometabolic Diseases: The Role of AMPK. Int J Mol Sci. 2023;24(15). Epub 20230726. pmid:37569362; PubMed Central PMCID: PMC10418890.
- 7. Del Carmen Camacho-Rea M, Martinez-Gomez LE, Martinez-Armenta C, Martinez-Nava GA, Ortega-Pena S, Olea-Torres J, et al. Association of TLR8 Variants in Sex-Based Clinical Differences in Patients with COVID-19. Biochem Genet. 2024. Epub 20240530. pmid:38814383.
- 8. Cheng ZJ, Xue M, Zheng P, Lyu J, Zhan Z, Hu H, et al. Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review. Vaccines (Basel). 2021;9(8). Epub 20210805. pmid:34451994; PubMed Central PMCID: PMC8402513.
- 9. Kodde C, Tafelski S, Balamitsa E, Nachtigall I, Bonsignore M. Factors Influencing Antibody Response to SARS-CoV-2 Vaccination. Vaccines (Basel). 2023;11(2). Epub 20230215. pmid:36851326; PubMed Central PMCID: PMC9967627.
- 10. Nam SY, Jeon SW, Lee HS, Lim HJ, Lee DW, Yoo SS. Demographic and Clinical Factors Associated With Anti-SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine Doses. JAMA Netw Open. 2022;5(5):e2212996. Epub 20220502. pmid:35587345; PubMed Central PMCID: PMC9121186.
- 11. Kara Z, Akcin R, Demir AN, Dinc HO, Kocazeybek B, Yumuk VD. Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with Obesity. Obes Facts. 2023;16(4):374–80. Epub 20230525. pmid:37231909; PubMed Central PMCID: PMC10443995.
- 12. Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, et al. Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab Res Rev. 2022;38(1):e3465. Epub 20210511. pmid:33955644; PubMed Central PMCID: PMC8209952.
- 13. Fishkin T, Goldberg MD, Frishman WH. Review of the Metabolic Risk Factors for Increased Severity of Coronavirus Disease-2019. Cardiol Rev. 2021;29(6):292–5. pmid:34261900; PubMed Central PMCID: PMC8489576.
- 14. Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9(11):786–98. Epub 20211004. pmid:34619105; PubMed Central PMCID: PMC8489878.
- 15. Rodrigues MES, Bolen ML, Blackmer-Raynolds L, Schwartz N, Chang J, Tansey MG, et al. Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer’s disease. Neurobiol Dis. 2024;196:106511. Epub 20240424. pmid:38670277.
- 16. Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, et al. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis. 2014;67:79–87. Epub 20140329. pmid:24686304; PubMed Central PMCID: PMC4083060.
- 17. Watanabe M, Balena A, Masi D, Tozzi R, Risi R, Caputi A, et al. Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine. Vaccines (Basel). 2022;10(1). Epub 20220105. pmid:35062740; PubMed Central PMCID: PMC8780354.
- 18. Fischinger S, Boudreau CM, Butler AL, Streeck H, Alter G. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(2):239–49. Epub 20181213. pmid:30547182; PubMed Central PMCID: PMC6373179.
- 19. Kara Z, Akcin R, Demir AN, Dinc HO, Taskin HE, Kocazeybek B, et al. Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity. Obes Surg. 2022;32(9):2987–93. Epub 20220708. pmid:35802279; PubMed Central PMCID: PMC9263798.
- 20. Gonzalez-Barranco J, Lopez-Alvarenga JC, Roiz-Simancas M, Bravo-Garcia AL, Fanghanel-Salmon G, Laviada Arrigunaga E, et al. [Migration from a rural zone to an urban one is associated with android distribution of body fat in obese women]. Rev Invest Clin. 2001;53(2):129–35. pmid:11421108.
- 21. Landeros-Olvera E, Lopez-Alvarenga JC, Nava-Gonzalez EJ, Gallegos-Cabriales E, Lavalle-Gonzalez F, Bastarrachea RA, et al. [Cardiovascular exercise on obese women: effects on adiponectine, leptine, and tumour necrosis factor-alpha]. Arch Cardiol Mex. 2014;84(3):177–82. Epub 20140801. pmid:25091615.
- 22. Madison AA, Shrout MR, Renna ME, Kiecolt-Glaser JK. Psychological and Behavioral Predictors of Vaccine Efficacy: Considerations for COVID-19. Perspect Psychol Sci. 2021;16(2):191–203. Epub 20210127. pmid:33501900; PubMed Central PMCID: PMC7841255.
- 23. Dragos D, Tanasescu MD. The effect of stress on the defense systems. J Med Life. 2010;3(1):10–8. pmid:20302192; PubMed Central PMCID: PMC3019042.
- 24. Eidson LN, deSousa Rodrigues ME, Johnson MA, Barnum CJ, Duke BJ, Yang Y, et al. Chronic psychological stress during adolescence induces sex-dependent adulthood inflammation, increased adiposity, and abnormal behaviors that are ameliorated by selective inhibition of soluble tumor necrosis factor with XPro1595. Brain Behav Immun. 2019;81:305–16. Epub 20190625. pmid:31251975; PubMed Central PMCID: PMC8597195.
- 25. Dolgin E. The tangled history of mRNA vaccines. Nature. 2021;597(7876):318–24. pmid:34522017.
- 26. Ayon-Nunez DA, Cervantes-Torres J, Cabello-Gutierrez C, Rosales-Mendoza S, Rios-Valencia D, Huerta L, et al. An RBD-Based Diagnostic Method Useful for the Surveillance of Protective Immunity against SARS-CoV-2 in the Population. Diagnostics (Basel). 2022;12(7). Epub 20220705. pmid:35885534; PubMed Central PMCID: PMC9324632.
- 27. Garcia-Oropesa EM, Perales-Torres AL, Martinez-Lopez YE, Munguia-Cisneros CX, Nava-Gonzalez EJ, Perez-Navarro M, et al. Effect of Insulin Resistance on Abdominal Obesity, Liver Fat Infiltration, and Body Mass Index in Youngsters. Arch Med Res. 2023;54(7):102873. Epub 20230901. pmid:37660428.
- 28.
Barraza-Macias A. El estrés de la pandemia (COVID 19) en población Mexicana.: Centro de Estudios Clinica e Investigacion Psicoanalitica S.C.; 2020.
- 29. Lopez-Alvarenga JC, Vazquez-Velazquez V, Bolado-Garcia VE, Gonzalez-Barranco J, Castaneda-Lopez J, Robles L, et al. [Parental influence in children’s food preferences. The ESFUERSO study in two primary schools with different socioeconomic gradients]. Gac Med Mex. 2007;143(6):463–9. pmid:18269076.
- 30. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care. 1999;22(10):1655–9. pmid:10526730.
- 31. Chatterjee S, Yilmaz M. A Review of Regression Diagnostics for Behavioral Research. Applied Psychological Measurement. 1992;16(3):209–27.
- 32. Marquardt DW. Generalized Inverses, Ridge Regression, Biased Linear Estimation, and Nonlinear Estimation. Technometrics. 1970;12(3):591–612.
- 33.
Detecting and Assessing Collinearity. Regression Diagnostics1980. p. 85–191.
- 34.
Network. E. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. 2023 [updated March 6, 2023.October 25, 2023.]. Available from: https://www.equator-network.org/reporting-guidelines/strobe/].
- 35. Kim D, Memili A, Chen HH, Highland HM, Polikowsky HG, Anwar MY, et al. Sex-specific associations between adipokine profiles and carotid-intima media thickness in the Cameron County Hispanic Cohort (CCHC). Cardiovasc Diabetol. 2023;22(1):231. Epub 20230831. pmid:37653519; PubMed Central PMCID: PMC10472619.
- 36. Montes-Herrera D, Munoz-Medina JE, Fernandes-Matano L, Salas-Lais AG, Hernandez-Cueto MLA, Santacruz-Tinoco CE, et al. Association of Obesity with SARS-CoV-2 and Its Relationship with the Humoral Response Prior to Vaccination in the State of Mexico: A Cross-Sectional Study. Diagnostics (Basel). 2023;13(16). Epub 20230809. pmid:37627889; PubMed Central PMCID: PMC10453006.
- 37. Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, et al. Sex-associated differences between BMI and SARS-CoV-2 antibody titers following the BNT162b2 vaccine. Obesity (Silver Spring). 2022;30(5):999–1003. Epub 20220412. pmid:35226399; PubMed Central PMCID: PMC9088326.
- 38. Ou X, Jiang J, Lin B, Liu Q, Lin W, Chen G, et al. Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13078. Epub 20221219. pmid:36535669; PubMed Central PMCID: PMC9835425.